Head-to-Head

Johnson & Johnson vs. Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

JNJ

Johnson & Johnson

$269.19 -0.10%

VS KNSA

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

$78.13 +1.15%

Johnson & Johnson (JNJ) comes out ahead, leading on 8 of 9 compared factors.

Size & Scale

JNJKNSA
Market Cap $649.40 billion $6.03 billion
Revenue (TTM) $97.93 billion $840.85 million
Net Income (TTM) $21.04 billion $80.66 million

JNJ leads on 3 of 3 size & scale factors.

Valuation

JNJKNSA
P/E Ratio 31.23 78.92
Price / Book 7.64 9.21
Price / Sales 6.63 7.17

JNJ leads on 3 of 3 valuation factors.

Profitability

JNJKNSA
Net Margin 21.48% 9.59%
Return on Equity 24.76% 12.33%

JNJ leads on 2 of 2 profitability factors.

Dividend

JNJKNSA
Dividend Yield 1.99% —
Payout Ratio 62.18 —

JNJ and KNSA split the dividend factors evenly.

Risk & Sentiment

JNJKNSA
Short Interest 0.67% 0.02%

KNSA leads on 1 of 1 risk & sentiment factors.

Dig deeper: JNJ overview, JNJ financials, KNSA overview, KNSA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.